Volume of dead space and equivalent units of insulin in five syringes Can amiodarone induce hyperglycaemia and hypertriglyceridaemia?
(Everett) 0-063 2-52 (U40) New BS 1619 1 ml glass insulin syringe (UIOO insulin) + 26 gauge, 0-5 inch needle (Rand Rocket) 0-051 5 1 (UIOO) New BS 1619 0 5 ml glass insulin syringe (UI00 insulin) + 26 gauge, 0-5 inch needle (Rand Rocket) 0-05 5 (U100) BD Plastipak 1 ml plastic disposable syringe (U100 insulin) with integral 27 gauge, 0-5 inch needle 0 011 1 1 (U100)
Comment
The importance of dead space may be seen from the following example. A patient prescribed a mixture of 10 units of neutral insulin and 20 units of insulin zinc suspension and using a U100 glass syringe, which has a dead space equivalent to 5 units, will draw into the syringe 15 Can amiodarone induce hyperglycaemia and hypertriglyceridaemia?
Amiodarone is an iodinated derivative of benzofuran and is structurally similar to thyroxine. Its long term use has caused thyroid gland dysfunction,' corneal microdeposits and cutaneous pigmentation,2 pneumonitis and pulmonary fibrositis,3 neuropathy,4 and potentiation of anticoagulation with warfarin.5 We report on three patients treated with amiodarone who presented with abnormalities of carbohydrate and lipid metabolism but normal thyroid function.
Case reports
Case 1-A 71 year old woman who was taking digoxin and frusemide 25 mg every other day for heart failure had blood glucose, triglyceride, and cholesterol concentrations in the normal range. She was given oral amiodarone 200 mg every other day for rapid atrial fibrillation. One year later she developed hyperglycaemia, glycosuria (0-28 mol (50 g)/24 h), hypercholesterolaemia, and hypertriglyceridaemia (table). Serum concentrations of triiodothyronine, thyroxine, and thyroid stimulating hormone were in the normal range (2-2 nmol/l (142 ng/100 ml), 98 nmol/l (7-5 jzg/100 ml), and 7-2 mU/1 respectively). Amiodarone was stopped, but treatment with diuretics was not changed. Twenty days later she showed normal fasting and postprandial blood glucose concentrations and reduced cholesterol and triglyceride concentrations ( Case 3-A 58 year old man was admitted to hospital for an anterior myocardial infarction with subsequent ventricular aneurysm complicated by three episodes of ventricular fibrillation and peripheral embolii. He was given coumarins, diuretics (spironolactone 25 mg and hydrochlorothiazide 25 mg daily), dipyridamole 75 mg, isosorbide dinitrate 50 mg, and mexiletine 50 mg all thrice daily, and oral amiodarone 1-6 g weekly after a loading dose. Before treatment he had normal cholesterol, triglyceride, and fasting blood glucose concentrations. We were unable subsequently to stop treatment with amiodarone despite a progressive moderate increase in triglyceride concentration. Cholesterol, fasting blood glucose, serum triiodothyronine (1.3 nmol/l (85 ng/100 ml)) and thyroxine (124 nmol/l (9 6 ,ug/100 ml)) concentrations remained normal (table) without any change in dosage of diuretics. One month after the dosage of amiodarone was reduced to 10 g weekly, however, the triglyceride concentration had decreased to 2-3 mmol/l (207 mg/100 ml) and cholesterol concentration to 5 mmol/l (193 mg/100 ml) without any change in fasting blood glucose concentration. Conversion: SI to traditional units-Glucose: 1 mmol/lz 18 mg/100 ml. Cholesterol: 1 mmol/lz 38-7 mg/100 ml. Triglycerides: 1 mmol/l 88-6 mg/100 ml.
Comment
Even though one of our patients (case 2) already had slightly impaired glucose tolerance before treatment and in another (case 3) we were unable to withdraw amiodarone to show complete reversal of hypertriglyceridaemia, our findings indicate that hyperglycaemia and hypertriglyceridaemia are possible side effects of treatment with amiodarone.
